Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 21 May 2012 | By Ansis Helmanis,
A notice (Ordinance No. 748-B/2012) published by Anvisa on 18 May sets forth the criteria the agency will use for classifying materials as confidential and thus ineligible for release under the Access to Information Act, which recently went into effect.
Examples of what would be classified as non-releasable is information relating to: scientific studies and research projects in progress, intelligence activities, ongoing monitoring, and information treated as confidential in connection with other international bodies.
The agency also established a Permanent Committee for the Evaluation of secret documents (748-A/2012 Ordinance) that will, among other things, advise Anvisa on the classification of sensitive information and prepare an annual list of classified and declassified documents, which will be available on the Internet.
Read more:
Ordinance No. 748-B/2012
Ordinance No. 748-A/2012
More Breaking News from RegLink
Tags: Access to Information Law, Freedom of Information, FOIA, Transparency, information